MYCN and neuroblastoma: PERK inhibition with an optimized kinase inhibitor, GSK2606414 (Axten et al, 2013), reduces autophagy in MYCN‐amplified neuroblastoma cells and further enhances the efficacy of GLI inhibitor in repressing the growth of these cells in vitro and in vivo (Wang et al, 2018).